Translational Cancer Research

Metrics & Ranking

Impact Factor

Year	Value
2025	1.7
2024	1.50

SJR (SCImago Journal Rank)

Year	Value
2024	0.521

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	43

Journal Rank

Year	Value
2024	11161

Journal Citation Indicator

Year	Value
2024	2139

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• The role of deep learning and radiomic feature extraction in cancer-specific predictive modelling: a review

  Citation: 175

  Authors: Alanna, David, Matthew, Montserrat, Christian, Martin, Lois, Alexis A.

• Exosomal lncRNAs as new players in cell-to-cell communication

  Citation: 149

  Authors: Mihnea, Baoqing, George A.

• Functions of polyphenols and its anticancer properties in biomedical research: a narrative review

  Citation: 140

  Authors: Pritam Bhagwan, Sang Eun, Preethi, Hun Hwan, Seong Min, Gon Sup

• TP53 mutations in epithelial ovarian cancer

  Citation: 109

  Authors: Yu, Lan, Daniel, Hua

• Radiomics in head and neck cancer: from exploration to application

  Citation: 106

  Authors: Andrew J., Aasheesh, Abdallah S., Clifton D.

• Prostate cancer radiomics and the promise of radiogenomics

  Citation: 103

  Authors: Radka, Mandeep, Yohann, John C., Gabriel, Nicholas, Yoganand, Sanoj, Elai, Robert J., Alan

• Impact of image preprocessing on the volume dependence and prognostic potential of radiomics features in non-small cell lung cancer

  Citation: 98

  Authors: Xenia, Lifei, Jinzhong, Dennis, Peter, Daniel, David, A. Kyle, Francesco, Laurence E.

• Renal cell carcinoma: the search for a reliable biomarker

  Citation: 92

  Authors: Nicholas J., Christopher J., Parth K., Jane D., Evita T., Eric A.

• EGFR first- and second-generation TKIs—there is still place for them in EGFR-mutant NSCLC patients

  Citation: 85

  Authors: Niki, Manuel, Jillian Wilhelmina Paulina, Rafael

• Translational Cancer Research

  Citation: 77

  Authors:

---